Basal cell carcinoma medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 45: Line 45:
|}
|}


The algorithm below demonstrates a treatment protocol for '''low-risk''' patients that can tolerate surgery <ref>http://www.nccn.org/patients/guidelines/nscl/#56/z</ref>.  
The algorithm below demonstrates a treatment protocol for '''low-risk''' lesions<ref>http://www.nccn.org/professionals/physician_gls/PDF/nmsc.pdf</ref>.  


[[Image:Stage I.jpg|800px]]
[[Image:Low Risk Basal Cell.jpg|800px]]
 
The algorithm below demonstrates a treatment protocol for '''high-risk''' lesions<ref>http://www.nccn.org/professionals/physician_gls/PDF/nmsc.pdf</ref>.
 
[[Image:Low Risk Basal Cell.jpg|800px]]





Revision as of 18:30, 23 July 2015

Basal cell carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Basal Cell Carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

CT scan

MRI

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Basal cell carcinoma medical therapy On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Basal cell carcinoma medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Basal cell carcinoma medical therapy

CDC on Basal cell carcinoma medical therapy

Basal cell carcinoma medical therapy in the news

Blogs on Basal cell carcinoma medical therapy

Directions to Hospitals Treating Basal cell carcinoma

Risk calculators and risk factors for Basal cell carcinoma medical therapy

Overview

Basal Cell Carcinoma Medical Therapy

After the suspicious lesion is evaluated, the medical therapy is divided into low-risk and high-risk basal carcinoma patients.

The table below summarizes the characteristics in low-risk and high-risk lesions[1].

H&P Low Risk High Risk
Location/size Area L <20 mm; Area M <10 mm; Area H <6 mm Area L ≥20 mm; Area M ≥10 mm; Area H ≥6 mm
Borders Well defined Poorly defined
Primary vs. recurrent Primary Recurrent
Immunosuppression (-) (+)
Site of prior radiation therapy (-) (+)
Subtype Nodular, superficial Aggressive growth pattern
Perineural involvement (-) (+)

The algorithm below demonstrates a treatment protocol for low-risk lesions[2].

The algorithm below demonstrates a treatment protocol for high-risk lesions[3].


References